1 🕐 2-6 Weeks

Market Readiness Assessment

Diagnose the gap between "we have a product" and "pharma will buy it."

The Problem: Most health tech founders think they're further along than they are. They spend 12-18 months chasing pilots before realizing they're missing critical requirements—validation packages, compliance certifications, integration capabilities—that pharma actually demands.

The Solution: A rapid, comprehensive assessment that tells you exactly where you stand. No sugarcoating. No generic frameworks. Specific gaps, prioritized recommendations, and realistic timelines based on years of pharma market experience.

What You Get:

  • Product-market fit analysis against actual pharma buying criteria
  • Compliance gap assessment (SOC 2, 21 CFR Part 11, GDPR, etc.)
  • Operational readiness assessment (project management, customer service, QA support)
  • Competitive positioning snapshot
  • Prioritized roadmap with realistic timelines
  • Go/no-go recommendation with specific next steps

Best For: Early-stage health tech companies preparing for first pharma pilots, or growth-stage companies hitting unexpected resistance in enterprise sales.

Take a Quick Self-Assessment →
2 🕐 6-9 Months (Phased)

Comprehensive Commercialization Strategy

Full-scale market entry strategy with built-in decision gates.

The Problem: You need more than a readiness assessment—you need a complete go-to-market strategy. But you also can't afford to commit to a the full 6-9 month engagement without knowing it's working.

The Solution: A three-phase engagement with decision gates after each phase. You can stop at any checkpoint with deliverables in hand. No lock-in, no wasted investment. Engagement durations dependent on product complexity, organizational readiness, and client response times.

Phase 1: Product and Process Audit (6-10 weeks)

  • Deep-dive product assessment against pharma requirements
  • Technical architecture review for enterprise readiness
  • Compliance and regulatory gap analysis
  • Operational readiness review
  • Competitive landscape mapping

Decision Gate: Continue or stop with actionable audit report.

Phase 2: Market Opportunity Blueprint (8-12 weeks)

  • Target customer segmentation and prioritization
  • Value proposition development by stakeholder type
  • Pricing strategy and business model optimization
  • Partnership and channel strategy

Decision Gate: Continue or stop with market strategy document.

Phase 3: Go-to-Market Roadmap (8-12 weeks)

  • Sales process design for pharma buying cycles
  • Marketing and content strategy
  • Pilot program design and success metrics
  • Team structure and capability requirements

Best For: Health tech companies with initial product-market validation seeking systematic pharma market entry, or companies repositioning after failed initial attempts.

3 🕐 6-10 Weeks (Modular)

Rapid Market Entry Strategy—Modular

Fast-track specific capabilities when time is critical.

The Problem: You don't have 6-9 months. You have investor pressure, a competitive window, or a specific opportunity that requires immediate action on a particular capability.

The Solution: Modular engagements focused on your highest-priority need. Choose one module or combine several based on your timeline and budget.

Available Modules:

Pilot Acquisition Sprint

Target identification, outreach strategy, pitch development, and negotiation support to land your first 2-3 pharma pilots.

Competitive Positioning

Differentiation strategy against established and emerging benchmark competitors. Win themes and battle cards.

Workflow Mapping

Document how your solution integrates into pharma clinical operations workflows. Critical for stakeholder buy-in.

European Market Entry

GDPR compliance, EMA considerations, DACH region go-to-market strategy, and local partnership development.

Pricing & Packaging

Value-based pricing strategy, enterprise licensing models, and negotiation frameworks for pharma procurement.

Implementation & Scaling Readiness

Design the delivery infrastructure to match your commercial ambition — implementation workflows, client onboarding processes, resource planning, and team scaling roadmaps. So when you land that Top 20 pharma contract, you can actually deliver on it.

Best For: Companies with specific, time-sensitive needs who know exactly what capability gap they need to close.

4 🕐 Ongoing Retainer (min 3 months)

Fractional CxO / Advisory Retainer

Operational leadership or strategic guidance on an ongoing basis.

The Problem: You need experienced strategic, commercial, or operational leadership embedded in your team but can't justify (or afford) a full-time CxO. Or you've completed a strategy engagement and want ongoing guidance as you build internal capacity and execute.

The Solution: Two engagement models based on your needs:

Fractional CxO

Part-time executive leadership for scale-stage companies. Typically 2-3 days per week, focused on strategy, operations, or commercialization per defined needs. Includes:

  • Team leadership and development
  • Process design and optimization
  • KPI and customer success oversight
  • Executive team participation
  • Board and investor communication support

Advisory Retainer

Monthly strategic guidance without operational involvement. Typically 4-8 hours per month. Includes:

  • Monthly strategy sessions
  • On-call advisory for critical decisions
  • Deal review and negotiation support
  • Investor and board preparation
  • Network introductions and referrals

Best For: Scale-stage health tech companies (Series A+) needing experienced executive leadership or strategic guidance without full-time commitment.

Not Sure Which Service Fits?

Start with a conversation. Let's get to know each other in an initial introductory call. We'll discuss where you are on your unique journey and which engagement model makes sense. If it feels like we're a fit to work together, I'll submit a written proposal for you to review with your team, board, or investors as appropriate. We can still renegotiate scale from there.

Schedule a Call